Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a significant worldwide health problem with a poor prognosis. A borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) is a tumor with limited vascular involvement that is technically resectable but with a high risk of positive ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawaz, Ali, Abdel-Rahman, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805723/
https://www.ncbi.nlm.nih.gov/pubmed/36597515
http://dx.doi.org/10.2147/CMAR.S340719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805723/
https://www.ncbi.nlm.nih.gov/pubmed/36597515
http://dx.doi.org/10.2147/CMAR.S340719

Ejemplares similares